Investors / United States / DCVC
DCVC
Venture capital · Palo Alto, CA, United States · North America
DCVC is a deep tech venture capital firm that has backed entrepreneurs using computational approaches since 2010. It runs flagship funds and a separate life sciences arm, DCVC Bio, and reports over $4 billion in assets under management across 13 funds.
Invests inAI & Machine LearningHealthcare & Biotech
In its own wordsdeep techartificial intelligenceclimatecomputational biologydefensespace
Your fit with DCVC
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsDCVC lists 234 checked portfolio companies on its own site and is named in 48 funding rounds, 15 of them as lead. Its most frequent entry is Series A, 35% of the companies with a known first round. Its largest themes are AI & Machine Learning (29%), Healthcare & Biotech (19%) and Industrial & Manufacturing (9%). 84% of its companies are based in United States. It invests most often alongside Y Combinator, Andreessen Horowitz and Lux Capital.
Counts come from funding rounds that name DCVC, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not DCVC's whole history. Rounds on record name 48 companies; its own site lists 234. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundDCVC does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 28% |
| Series A | 35% |
| Series B | 13% |
| Growth | 24% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 2 | 0 |
| '18 | 1 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 1 | 0 |
| '24 | 4 | 1 |
| '25 | 13 | 5 |
| '26 | 26 | 9 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 99th | 234 companies |
| Recent activity | 99th | 29 rounds in 12 months |
| Early stage | 61th | 28% of entries at pre-seed or seed |
| Evidence | 89th | 17% of companies confirmed by a round |
| Sector focus | 49th | 29% in its largest sector |
| Reach | 96th | 11 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| AI & Machine Learning | 29% | 18% |
| Healthcare & Biotech | 19% | 15% |
| Industrial & Manufacturing | 9% | 7% |
| Cybersecurity | 7% | 4% |
| Fintech | 7% | 12% |
| Enterprise Software | 5% | 8% |
| Education | 5% | 7% |
| Space & Defense | 4% | 3% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Y Combinator | 40 |
| Andreessen Horowitz | 16 |
| Lux Capital | 16 |
| Salesforce Ventures | 10 |
| General Catalyst | 9 |
| Lowercarbon Capital | 9 |
| NEA | 9 |
| SV Angel | 9 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers22194%
- No longer answers00%
- Points to another company136%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare DCVC head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with DCVC| Date | Company | Stage |
|---|---|---|
| 12 Nov 2026 | Series C+ | |
| 5 Nov 2026 | Seed Led | |
| 3 Nov 2026 | Seed | |
| 22 Oct 2026 | Seed | |
| 8 Oct 2026 | Series A Led | |
| 24 Sept 2026 | Seed | |
| 22 Sept 2026 | Seed | |
| 21 Sept 2026 | Series B |
Round details for DCVC
Amounts, full round histories and every co-investor in DCVC's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
234 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AbCellera develops and studies antibody medicines for various therapeutic areas, including endocrinology, immunology, and autoimmunity. | Healthcare & Biotech | Portfolio page | ||
| Aclarity destroys PFAS contaminants on-site with its Octa System | Industrial & ManufacturingEnterprise Software | Portfolio page | ||
| Aclima provides air measurement and analysis services using a network of sensors to map and analyze air pollution and greenhouse gases. | Healthcare & BiotechClimate & Energy | Portfolio page | ||
| Agility Robotics designs and deploys humanoid robots for industrial automation | Robotics & HardwareIndustrial & Manufacturing | Portfolio page | ||
| AgZen develops and sells a system that measures and controls droplet coverage on every leaf for agricultural sprayers | AI & Machine LearningAI & Machine Learning | Mar 2026Series B | Page + round | |
| AIM commercially deploys autonomous earthmoving solutions for industries such as mining, construction, and defense | Industrial & ManufacturingAI & Machine Learning | Portfolio page | ||
| Airtable provides a platform for building custom applications and workflows | Enterprise SoftwareAI & Machine Learning | Portfolio page | ||
| The company does organism level drug discovery | Healthcare & Biotech | Portfolio page | ||
| Akash Systems builds and delivers GPU servers that use diamond cooling technology for AI computing | AI & Machine LearningSpace & Defense | Portfolio page | ||
| Akido Labs offers various insurance services, including life, disability, mental health coverage, medical reimbursement, and accident insurance. | Healthcare & BiotechFintech | Portfolio page | ||
| Alation sells a software platform for data cataloging, data governance, and managing the accuracy of data and AI agents. | Enterprise SoftwareAI & Machine Learning | Portfolio page | ||
| Alchemab Therapeutics develops antibody therapeutics for hard to treat diseases using the immune system | Healthcare & Biotech | Sept 2025Series A | Page + round | |
| AlphaGeo combines location and climate intelligence to help investors and businesses identify emerging opportunities, assess risks, and build long-term resilience. | FintechClimate & Energy | Portfolio page | ||
| Amogy provides onsite power and ammonia energy solutions, including power generation and hydrogen production systems. | EducationEducation | Portfolio page | ||
| Amplitude provides analytics and AI-powered tools to help product teams build and improve their products. | Media & EntertainmentE-commerce & Marketplaces | Portfolio page | ||
| Anjuna provides cloud data security and privacy preserving AI solutions | CybersecurityAI & Machine Learning | Portfolio page | ||
| Aquafortus treats high salinity brines by selectively removing water rather than filtering contaminants using its ABX system. | Industrial & ManufacturingOther | Portfolio page | ||
CybersecurityAI & Machine Learning | Portfolio page | |||
| Ascend Advanced Therapies supports the development of advanced therapies, including gene therapies, immunotherapies, oncolytics, and vaccines, from research to commercialization | Healthcare & Biotech | Portfolio page | ||
| Asimov designs and manufactures genetic systems and therapies using synthetic biology and computational tools. | Healthcare & Biotech | Dec 2017Seed | Page + round |
About this data
site last read 5 Nov 2026- Site
- dcvc.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 9 Jun 2014
- Companies checked
- 234
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get DCVC's profile as data
Pull DCVC's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/dcvc.com
# also
GET /v1/firms/dcvc.com/portfolio
GET /v1/firms/dcvc.com/coinvestors
GET /v1/firms/dcvc.com/news